{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: BACKGROUND : Our aim was to investigate postoperative complications and mortality after administration of aprotinin compared to tranexamic acid in an unselected , consecutive cohort .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| There are no disease entities mentioned in the paragraph. |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| There are no disease entities mentioned in the paragraph. |\n\nThe paragraph does not contain any explicit mention of a disease."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: BACKGROUND : Our aim was to investigate postoperative complications and mortality after administration of aprotinin compared to tranexamic acid in an unselected , consecutive cohort .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| aprotinin |\n| tranexamic acid |\n\nExplanation:\n\nThe two chemical entities present in the paragraph are:\n\n1. aprotinin: It is a polypeptide with a molecular weight of 6500 daltons, and it is a naturally occurring inhibitor of several proteolytic enzymes, including trypsin, chymotrypsin, and plasmin.\n2. tranexamic acid: It is an antifibrinolytic agent used for the prevention and treatment of bleeding. It works by inhibiting the activation of plasminogen to plasmin and stabilizing the fibrin clot."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| aprotinin |\n| tranexamic acid |\n\nExplanation:\n\nThe two chemical entities present in the paragraph are:\n\n1. aprotinin: It is a polypeptide with a molecular weight of 6500 daltons, and it is a naturally occurring inhibitor of several proteolytic enzymes, including trypsin, chymotrypsin, and plasmin.\n2. tranexamic acid: It is an antifibrinolytic agent used for the prevention and treatment of bleeding. It works by inhibiting the activation of plasminogen to plasmin and stabilizing the fibrin clot.\n\nThere are no other entities in the paragraph that clearly refer to \"Chemical\" that need to be removed."}
  ]
}